BNET Industries
- Public
- US
Dow Jones Description
Advanced Biotherapy, Inc. is a corporation organized and existing under the laws of the State of Delaware, headquartered in Woodland Hills, California with laboratories in Columbia, Maryland. The Company has demonstrated the effectiveness of its pioneering scientific strategy in the use of therapeutic antibodies by conducting investigational clinical trials treating patients suffering from AIDS, multiple sclerosis, rheumatoid arthritis, corneal transplant rejection, uveitis and certain autoimmune skin conditions, including psoriasis, and alopecia, all Th1 mediated autoimmune diseases which appear to have the same proinflammatory Th-1 activity. To date, our activities have consisted primarily of research, development and non-United States investigational human clinical trials. Such activities have resulted in accumulated losses at December 31, 2004. Our Company is developing a biologic therapeutic approach for treating a range of autoimmune diseases based on an anti-cytokine platform technology.
Contact Information
227 West Monroe
Suite 3900
Chicago, Illinois 60606
312-701-0793
Peer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
Recent Events
-
Lime Energy Co. Completes Previously Announced Acquisition
News & Analysis
Filter by
advanced biotherapy inc. - All News and Analysis
Advanced Biotherapy Inc. Receives ``Notice of Allowance'' from Patent Office for Use of Antibodies to Treat Uveitis
LOS ANGELES -- Company Expands Antibody Patent Portfolio for Treatment of Eye Disease and Plans to Develop Franchise for Treatment of Ocular Diseases Advanced Biotherapy, Inc. (OTCBB:ADVB), dedicated to pioneering the development and use of therapeutic antibodies, announced that the Company has received a "Notice of Allowance" from the...
Advanced Biotherapy Inc. Broadens Its Patent Estate
Business Editors/Health & Medical Writers LOS ANGELES--BUSINESS WIRE--March 18, 2003 Advanced Biotherapy Inc. (OTCBB:ADVB) was notified by the United States Patent and Trademark Office USPTO that it has been issued U.S. Patent No. 6,534,059 for the use of antibody to gamma interferon to treat corneal transplant rejection. The...
Advanced Biotherapy Inc. Receives `Notice of Allowance' From United States Patent and Trademark Office for Use of Antibodies to Gamma Interferon to Treat Corneal Transplant Rejection
Business Editors & Health/Medical Writers LOS ANGELES--BUSINESS WIRE--Dec. 2, 2002 Advanced Biotherapy Inc. (OTCBB:ADVB) has received a "Notice of Allowance" from the United States Patent and Trademark Office USPTO for a utility patent for the use of any form of antibody to gamma interferon to treat corneal transplant...
Advanced Biotherapy, Inc. Discloses Use Patent for Antibodies to Interferon-Gamma in the Treatment of Five Autoimmune Diseases
Business Editors, Health/Medical Writers WOODLAND HILLS, Calif.--BW HealthWire--Dec. 13, 2001 Advanced Biotherapy, Inc. (OTCBB: ADVB) announced today that antibodies to interferon-gamma (IFN-g) are now protected under U.S. patent law for use in five diseases of autoimmune etiology. The announcement of the assignment of this patent number coincides with...
Advanced Biotherapy Inc. Receives 'Notice of Allowance' for Antibody Utility Patent to Treat Autoimmune Diseases
Health/Medical Writers & Business Editors LOS ANGELES--BW HealthWire--Aug. 20, 2001 Advanced Biotherapy Inc. (OTCBB:ADVB) has received a "notice of allowance" from the United States Patent and Trademark Office USPTO for a utility patent to be issued for an antibody to treat five autoimmune diseases. The patent is...
Advanced Biotherapy Inc. Announces Filing of Form 10-QSB With The Securities and Exchange Commission
Business Editors WOODLAND HILLS, Calif.--BUSINESS WIRE--May 15, 2001 Advanced Biotherapy Inc. (OTCBB:ADVB) today announced that the company electronically filed its form 10-QSB, for the quarter ended March 31, 2001, with the Securities and Exchange Commission. The filing can be obtained electronically at http://www.edgar-online.com/brand/aol/glimpse/glimpse.pl?sym=ADVB.
Additional Resources
Advanced Biotherapy, Inc. Announces Material Transactions
CHICAGO -- Advanced Biotherapy, Inc. (OTCBB:ADVB) announced today that, because it believes organic dairy products are a dynamic growth industry, it has made an investment in Organic Farm Marketing, LLC ("OFM"), a Wisconsin limited liability company, which distributes dairy products. The Company acquired from OFM a convertible note...
Advanced Biotherapy, Inc. Announces Results of Rights Offering
CHICAGO -- Advanced Biotherapy, Inc. (OTCBB: ADVB) announced today that it raised approximately $590,000 in its recently completed rights offering to stockholders of record as of June 5, 2007. The Company reported that its stockholders exercised their subscription rights to purchase 39,251,888 shares of the Company's common stock at $0.015...
Advanced Biotherapy, Inc. Sets Record Date for Rights Offering
CHICAGO -- Advanced Biotherapy, Inc. today announced that it is setting June 5, 2007, as the record date for its rights offering. Only holders of record of the Company's stock as of the close of business on the record date will be eligible to participate in the rights offering. Generally,...
Advanced Biotherapy Restated 2004, 2005 and 2006 Financial Statements
CHICAGO -- Advanced Biotherapy, Inc. (OTCBB:ADVB) announced today that it restated its 2004 and 2005 audited financial statements and its 2006 quarterly unaudited financial statements as follows: [TABLE OMITTED] Company President and Chief Executive Officer, Christopher W. Capps said today that "the restatements correct accounting items identified by...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Richard P. Kiphart | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| David Valentine | Board of Directors |
David W. Valentine has been one of our directors since May 2004. Mr. Valentine is currently the chief operating officer and a founding principal of Victory Park Capital, a private investment firm. Prior to co-founding Victory Park, Mr. Valentine served as the portfolio manager of Private Investments for a Chicago-based hedge fund as well as the Global Head Debt Private Placements for UBS Investment Bank. Prior to UBS, Mr. Valentine held several investment banking positions at ABNAMRO and Harris Nesbitt. Mr. Valentine also serves on the board of directors for Innovomed, Inc., Advanced Biotherapy, Inc. and Trustwave, Inc. He is also on the board of directors of a Washington DC-based advocacy group, the Friends of the Global Fight Against Aids, Tuberculosis, and Malaria. Mr. Valentine is the son-in-law of Richard Kiphart, our chairman.
| Organization | Position | Status |
|---|---|---|
| Victory Park | Founder | Current |
| Ambirontrustwave Limited | Board of Directors | Current |
| Lime Energy Co. | Board of Directors | Current |
| Advanced Biotherapy, Inc. | Board of Directors | Current |
| First Data Corporation | Former | |
| ABN AMRO Holding N.V. | Former | |
| Lime Energy Co. | Chair | Former |
| Harvard Business School | M.B.A. | Former |
| Dartmouth College | B.A. | Former |
| Organization | Position | Status |
|---|---|---|
| SAFLINK Corporation | Lead Independent Director | Current |
| William Blair Capital Partners | Head | Current |
| William Blair & Company, L.L.C. | Head of the Corporate Finance Department | Current |
| Investor Annex | Head of William Blair & Company's Corporate Finance Department | Current |
| William Blair & Company LLC | Principal | Current |
| Maximum Performance Group | Chairman | Current |
| Lime Energy Co. | Chairman of the Board | Former |
| SAFLINK Corporation | Director Co-Chairman of the Board, Lead Independent Director | Current |
| Emmi Solutions, LLC | Board of Directors | Current |
| SAFLINK Corporation | Director | Current |
| Nature Vision, Inc. | Director | Current |
| Advanced Biotherapy, Inc. | Director | Current |
| Data, Inc. | Board of Directors | Current |
| First Data Corporation | Director | Former |
| Lime Energy Co. | Board of Directors | Former |
| Harvard Business School | MBA | Former |
| Dartmouth College | B.A. | Former |
Industry Transcripts by Seeking Alpha
-
BMP Sunstone Corporation Q1 2009 Earnings Call Transcript
on Jun 30, 2009about BJGP
-
Matrixx Initiatives, Inc., F4Q09 (Qtr End 03/31/09) Earnings Call Transcript
on May 12, 2009about MTXX
-
King Pharmaceuticals Inc., Q1 2009 Earnings Call Transcript
on May 11, 2009about KG
-
Flamel Technologies SA Q1 2009 Earnings Call Transcript
on May 11, 2009about FLML
-
Sucampo Pharmaceuticals, Inc. Q1 2009 Earnings Call Transcript
on May 08, 2009about SCMP
Glass Door
IndustryTop Rated
- AstraZeneca's Seroquel Research Director Confessed to Sex-for-Studies Affairs 17 votes
- Forest Labs' Lexapro Flap Over JAMA Article Will Likely Be Examined by the Feds 11 votes
- Medarex Execs Got 10% Pay Raise Despite Delivering Nothing 11 votes
- Schering CEO Hassan Has $59 Million Buyout Agreement in Merck Merger 10 votes
- Gilead Whistleblower Suit: A Bullet Dodged 10 votes
